Skip to main content
Top
Published in: Infection 5/2011

01-10-2011 | Brief Report

Staphylococcus simulans as an authentic pathogenic agent of osteoarticular infections

Authors: M. Mallet, C. Loiez, H. Melliez, Y. Yazdanpanah, E. Senneville, X. Lemaire

Published in: Infection | Issue 5/2011

Login to get access

Abstract

Objectives

To evaluate the role of Staphylococcus simulans in bone and joint infections (BJI) and determine their main characteristics.

Methods

A search of the database of the microbiology laboratories of Lille hospital and Tourcoing hospital was performed. Only results from blood, bone, and orthopedic device cultures were taken into account for hospitalized patients between January 2004 and January 2009. We considered cases in which S. simulans was the only bacteria isolated in all of the patients’ biological samples with clinical and laboratory signs of infection. For patients with complete medical records, we recorded the clinical and epidemiological data.

Results

Six cases of BJI due to S. simulans were recorded, with five cases related to orthopedic devices infections. Three patients lived in rural areas. In four out of six patients, S. simulans was isolated in intraoperative biopsy material. In one patient, S. simulans grew in synovial fluid and in another in blood cultures only. The latter patient had a spondylodiscitis, and chronic foot ulcers due to gout disease were suspected to be the origin of the infection. All patients were healed after a mean follow up of 9 ± 3 months. Orthopedic devices were removed in four of the five patients concerned. The combination of rifampicin plus levofloxacin was used in four patients.

Conclusion

The present data suggest that, even though S. simulans remains rarely observed in clinical pathology, its role in osteoarticular infections, especially in the case of infected orthopedic devices, is not exceptional. As for the antibiotic treatment, the combination of rifampicin and levofloxacin seems to be an effective strategy according to our clinical results.
Literature
1.
go back to reference Males BM, Bartholomew WR, Amsterdam D. Staphylococcus simulans septicemia in a patient with chronic osteomyelitis and pyarthrosis. J Clin Microbiol. 1985;21:255–7.PubMed Males BM, Bartholomew WR, Amsterdam D. Staphylococcus simulans septicemia in a patient with chronic osteomyelitis and pyarthrosis. J Clin Microbiol. 1985;21:255–7.PubMed
2.
go back to reference Razonable RR, Lewallen DG, Patel R, Osmon DR. Vertebral osteomyelitis and prosthetic joint infection due to Staphylococcus simulans. Mayo Clin Proc. 2001;76:1067–70.PubMedCrossRef Razonable RR, Lewallen DG, Patel R, Osmon DR. Vertebral osteomyelitis and prosthetic joint infection due to Staphylococcus simulans. Mayo Clin Proc. 2001;76:1067–70.PubMedCrossRef
3.
go back to reference Sturgess I, Martin FC, Eykyn S. Pubic osteomyelitis caused by Staphylococcus simulans. Postgrad Med J. 1993;69:927–9.PubMedCrossRef Sturgess I, Martin FC, Eykyn S. Pubic osteomyelitis caused by Staphylococcus simulans. Postgrad Med J. 1993;69:927–9.PubMedCrossRef
4.
go back to reference Vallianou N, Evangelopoulos A, Makri P, Zacharias G, Stefanitsi P, Karachalios A, et al. Vertebral osteomyelitis and native valve endocarditis due to Staphylococcus simulans: a case report. J Med Case Rep. 2008;2:183.CrossRef Vallianou N, Evangelopoulos A, Makri P, Zacharias G, Stefanitsi P, Karachalios A, et al. Vertebral osteomyelitis and native valve endocarditis due to Staphylococcus simulans: a case report. J Med Case Rep. 2008;2:183.CrossRef
5.
go back to reference Senneville E, Savage C, Nallet I, Yazdanpanah Y, Giraud F, Migaud H, et al. Improved aero–anaerobe recovery from infected prosthetic joint samples taken from 72 patients and collected intraoperatively in Rosenow’s broth. Acta Orthop. 2006;77:120–4.PubMedCrossRef Senneville E, Savage C, Nallet I, Yazdanpanah Y, Giraud F, Migaud H, et al. Improved aero–anaerobe recovery from infected prosthetic joint samples taken from 72 patients and collected intraoperatively in Rosenow’s broth. Acta Orthop. 2006;77:120–4.PubMedCrossRef
6.
go back to reference Thorberg BM, Danielsson-Tham ML, Emanuelson U, Persson Waller K. Bovine subclinical mastitis caused by different types of coagulase-negative staphylococci. J Dairy Sci. 2009;92:4962–70.PubMedCrossRef Thorberg BM, Danielsson-Tham ML, Emanuelson U, Persson Waller K. Bovine subclinical mastitis caused by different types of coagulase-negative staphylococci. J Dairy Sci. 2009;92:4962–70.PubMedCrossRef
7.
go back to reference Penna B, Varges R, Medeiros L, Martins GM, Martins RR, Lilenbaum W. Species distribution and antimicrobial susceptibility of staphylococci isolated from canine otitis externa. Vet Dermatol. 2010;21:292–6.PubMedCrossRef Penna B, Varges R, Medeiros L, Martins GM, Martins RR, Lilenbaum W. Species distribution and antimicrobial susceptibility of staphylococci isolated from canine otitis externa. Vet Dermatol. 2010;21:292–6.PubMedCrossRef
8.
go back to reference Lilenbaum W, Esteves AL, Souza GN. Prevalence and antimicrobial susceptibility of staphylococci isolated from saliva of clinically normal cats. Lett Appl Microbiol. 1999;28:448–52.PubMedCrossRef Lilenbaum W, Esteves AL, Souza GN. Prevalence and antimicrobial susceptibility of staphylococci isolated from saliva of clinically normal cats. Lett Appl Microbiol. 1999;28:448–52.PubMedCrossRef
9.
go back to reference Kloos WE, Barnerman TL. Staphylococcus and Micrococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 7th ed. ASM Press: Washington; 1999. Kloos WE, Barnerman TL. Staphylococcus and Micrococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 7th ed. ASM Press: Washington; 1999.
10.
go back to reference McCarthy JS, Stanley PA, Mayall B. A case of Staphylococcus simulans endocarditis affecting a native heart valve. J Infect. 1991;22:211–2.PubMedCrossRef McCarthy JS, Stanley PA, Mayall B. A case of Staphylococcus simulans endocarditis affecting a native heart valve. J Infect. 1991;22:211–2.PubMedCrossRef
11.
go back to reference Ohshima Y, Schumacher-Perdreau F, Peters G, Pulverer G. The role of capsule as a barrier to bacteriophage adsorption in an encapsulated Staphylococcus simulans strain. Med Microbiol Immunol. 1988;177:229–33.PubMed Ohshima Y, Schumacher-Perdreau F, Peters G, Pulverer G. The role of capsule as a barrier to bacteriophage adsorption in an encapsulated Staphylococcus simulans strain. Med Microbiol Immunol. 1988;177:229–33.PubMed
12.
go back to reference Dupont C, Sivadon-Tardy V, Bille E, Dauphin B, Beretti JL, Alvarez AS, et al. Identification of clinical coagulase-negative staphylococci, isolated in microbiology laboratories, by matrix-assisted laser desorption/ionization-time of flight mass spectrometry and two automated systems. Clin Microbiol Infect. 2010;16:998–1004.PubMed Dupont C, Sivadon-Tardy V, Bille E, Dauphin B, Beretti JL, Alvarez AS, et al. Identification of clinical coagulase-negative staphylococci, isolated in microbiology laboratories, by matrix-assisted laser desorption/ionization-time of flight mass spectrometry and two automated systems. Clin Microbiol Infect. 2010;16:998–1004.PubMed
13.
14.
go back to reference Bindal M, Krabak B. Acute bacterial sacroiliitis in an adult: a case report and review of the literature. Arch Phys Med Rehabil. 2007;88:1357–9.PubMedCrossRef Bindal M, Krabak B. Acute bacterial sacroiliitis in an adult: a case report and review of the literature. Arch Phys Med Rehabil. 2007;88:1357–9.PubMedCrossRef
15.
go back to reference El Samad Y, Havet E, Bentayeb H, Olory B, Canarelli B, Lardanchet JF, et al. Treatment of osteoarticular infections with clindamycin in adults. Med Mal Infect. 2008;38:465–70.PubMedCrossRef El Samad Y, Havet E, Bentayeb H, Olory B, Canarelli B, Lardanchet JF, et al. Treatment of osteoarticular infections with clindamycin in adults. Med Mal Infect. 2008;38:465–70.PubMedCrossRef
Metadata
Title
Staphylococcus simulans as an authentic pathogenic agent of osteoarticular infections
Authors
M. Mallet
C. Loiez
H. Melliez
Y. Yazdanpanah
E. Senneville
X. Lemaire
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
Infection / Issue 5/2011
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-011-0173-x

Other articles of this Issue 5/2011

Infection 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine